WHITEHAWK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 81.53% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2026-06-30 was 81.53%, a 3.87% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2026-03-31 was 82.12%, a 8.23% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2025-06-30 was 84.81%, a 6.32% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2025-03-31 was 89.48%, a 2.16% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2025 was 89.48%, a 2.16% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2024 was 91.46%.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2021 was 87.88%, a 5.02% decline from fiscal 2020.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2020 was 92.52%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|---|---|---|
| 2026-06-30 | 81.53% 10-Q · filed 2026-08-06 | 82.12% 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 82.12% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 89.48% 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 89.48% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 84.81% 10-Q · filed 2026-08-06 | 89.48% 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 89.48% 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 91.46% 10-K · filed 2026-03-12 | |||
| 2024-09-30 | 91.46% 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 90.53% 10-Q · filed 2025-08-07 | 91.46% 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 91.46% 10-Q · filed 2025-05-08 | |||
| 2023-03-31 | 95.72% 10-Q · filed 2024-05-08 | |||
| 2022-03-31 | 86.25% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 87.88% 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 87.27% 10-Q · filed 2021-11-10 | 87.88% 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | 92.52% 10-K · filed 2022-03-17 | |||
| 2020-09-30 | 92.52% 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |